Literature DB >> 8564843

Insoluble wild-type and protease-resistant mutant prion protein in brains of patients with inherited prion disease.

R Gabizon1, G Telling, Z Meiner, M Halimi, I Kahana, S B Prusiner.   

Abstract

We studied prion proteins (PrP) in skin and brains of Libyan Jews carrying the E200K mutation who died of familial Creutzfeldt-Jakob disease (CJD). Unexpectedly, studies with brain showed that PrP molecules encoded both by the wild-type (wt) and mutant alleles exhibit altered properties characteristic of the prion protein associated with prion diseases (PrPSc). Using monospecific antisera, we found that wtPrP was insoluble in the brains of three patients who were heterozygous for the E200K mutation, whereas mutant PrP was both insoluble and protease-resistant. Our results argue that both wild-type and mutant PrP undergo conformational changes and are particularly intriguing, because the normal isoform PrPc is soluble in nondenaturing detergents and is readily digested by proteases, whereas PrPSc is insoluble and resistant to proteolytic digestion. Our findings indicate that insoluble wtPrP represents a conformational intermediate, the first to be identified, within a pathway in which PrPc is converted to PrPSc.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8564843     DOI: 10.1038/nm0196-59

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  26 in total

1.  Effect of the E200K mutation on prion protein metabolism. Comparative study of a cell model and human brain.

Authors:  S Capellari; P Parchi; C M Russo; J Sanford; M S Sy; P Gambetti; R B Petersen
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

2.  CEREBRAL AMYLOID ANGIOPATHY AND ALZHEIMER'S DISEASE.

Authors:  Jorge Ghiso; Yasushi Tomidokoro; Tamas Revesz; Blas Frangione; Agueda Rostagno
Journal:  Hirosaki Igaku       Date:  2010-07-08

3.  Detection of chronic wasting disease prion seeding activity in deer and elk feces by real-time quaking-induced conversion.

Authors:  Davin M Henderson; Joanne M Tennant; Nicholas J Haley; Nathaniel D Denkers; Candace K Mathiason; Edward A Hoover
Journal:  J Gen Virol       Date:  2017-07-13       Impact factor: 3.891

4.  Serial propagation of distinct strains of Aβ prions from Alzheimer's disease patients.

Authors:  Joel C Watts; Carlo Condello; Jan Stöhr; Abby Oehler; Joanne Lee; Stephen J DeArmond; Lars Lannfelt; Martin Ingelsson; Kurt Giles; Stanley B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-30       Impact factor: 11.205

5.  Requirements for mutant and wild-type prion protein misfolding in vitro.

Authors:  Geoffrey P Noble; Daniel J Walsh; Michael B Miller; Walker S Jackson; Surachai Supattapone
Journal:  Biochemistry       Date:  2015-01-22       Impact factor: 3.162

6.  Iowa variant of familial Alzheimer's disease: accumulation of posttranslationally modified AbetaD23N in parenchymal and cerebrovascular amyloid deposits.

Authors:  Yasushi Tomidokoro; Agueda Rostagno; Thomas A Neubert; Yun Lu; G William Rebeck; Blas Frangione; Steven M Greenberg; Jorge Ghiso
Journal:  Am J Pathol       Date:  2010-03-12       Impact factor: 4.307

7.  Genetic influence on the structural variations of the abnormal prion protein.

Authors:  P Parchi; W Zou; W Wang; P Brown; S Capellari; B Ghetti; N Kopp; W J Schulz-Schaeffer; H A Kretzschmar; M W Head; J W Ironside; P Gambetti; S G Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-29       Impact factor: 11.205

8.  Oxidation of Helix-3 methionines precedes the formation of PK resistant PrP.

Authors:  Tamar Canello; Kati Frid; Ronen Gabizon; Silvia Lisa; Assaf Friedler; Jackob Moskovitz; María Gasset; Ruth Gabizon
Journal:  PLoS Pathog       Date:  2010-07-01       Impact factor: 6.823

Review 9.  Molecular advances in understanding inherited prion diseases.

Authors:  David R Brown
Journal:  Mol Neurobiol       Date:  2002-06       Impact factor: 5.590

Review 10.  Cerebral amyloidosis: amyloid subunits, mutants and phenotypes.

Authors:  A Rostagno; J L Holton; T Lashley; T Revesz; Jorge Ghiso
Journal:  Cell Mol Life Sci       Date:  2009-11-07       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.